Wnt/β-catenin signaling contributes to skeletal myopathy in heart failure via direct interaction with forkhead box o

Circulation: Heart Failure

Volumn 8, Issue 4, 2015, Pages 799-808

  Okada, Katsuki ^a   Naito, Atsuhiko T ^a,b,c   Higo, Tomoaki ^a   Nakagawa, Akito ^a   Shibamoto, Masato ^a   Sakai, Taku ^a,b,c   Hashimoto, Akihito ^a,c   Kuramoto, Yuki ^a   Sumida, Tomokazu ^a   Nomura, Seitaro ^a,b,c   Ito, Masamichi ^c   Yamaguchi, Toshihiro ^c   Oka, Toru ^a,b   Akazawa, Hiroshi ^b   Lee, Jong Kook ^a,b   Morimoto, Sachio ^d   Sakata, Yasushi ^a   Shiojima, Ichiro ^b,e   Komuro, Issei ^b,c,f  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

complement C1q; Dilated cardiomyopathy; Forkhead box transcription factors; Heart failure; Serum; Skeletal muscle fibers; WNT beta catenin signaling pathway

Indexed keywords

BETA CATENIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FOXO; WNT PROTEIN; WNT3A PROTEIN; CTNNB1 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; WNT3A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEART FAILURE; MOLECULAR PATHOLOGY; MOUSE; MYOBLAST; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSACTIVATION; WNT SIGNALING PATHWAY; ANIMAL; CELL LINE; COMPLICATION; DISEASE MODEL; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUSCLE FATIGUE; MUSCULAR DISEASES; PATHOLOGY; PATHOPHYSIOLOGY; RNA INTERFERENCE; TRANSGENIC MOUSE;

ANIMALS; BETA CATENIN; CARDIOMYOPATHY, DILATED; CELL LINE; COMPLEMENT C1Q; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; MICE, TRANSGENIC; MUSCLE FATIGUE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DISEASES; RNA INTERFERENCE; TRANSFECTION; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84942881856     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001958     Document Type: Article

References (33)

1. Okita K, Kinugawa S, Tsutsui H. Exercise intolerance in chronic heart failure. Circ J. 2013;77:293-300.
2. Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res. 1996;79:128-136.
3. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail. 2010;3:537-546. doi: 10.1161/CIRCHEARTFAILURE.109.903773.
4. Greising SM, Gransee HM, Mantilla CB, Sieck GC. Systems biology of skeletal muscle: fiber type as an organizing principle. Wiley Interdiscip Rev Syst Biol Med. 2012;4:457-473. doi: 10.1002/wsbm.1184.
5. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81:518-527.
6. Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol. 2013;14:83-97. doi: 10.1038/nrm3507.
7. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399-412.
8. Yuan Y, Shi XE, Liu YG, Yang GS. FoxO1 regulates muscle fiber-type specification and inhibits calcineurin signaling during C2C12 myoblast differentiation. Mol Cell Biochem. 2011;348:77-87. doi: 10.1007/s11010-010-0640-1.
9. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, downregulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem. 2004;279:41114-41123. doi: 10.1074/jbc. M400674200.
10. Geng T, Li P, Yin X, Yan Z. PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice. Am J Pathol. 2011;178:1738-1748. doi: 10.1016/j.ajpath.2011.01.005.
11. Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res. 2005;97:418-426. doi: 10.1161/01.RES.0000179580.72375.c2.
12. Naito AT, Shiojima I, Akazawa H, Hidaka K, Morisaki T, Kikuchi A, Komuro I. Developmental stage-specific biphasic roles of Wnt/betacatenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A. 2006;103:19812-19817. doi: 10.1073/pnas.0605768103.
13. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469-480. doi: 10.1016/j.cell.2006.10.018.
14. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807-810. doi: 10.1126/science.1144090.
15. Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11-26. doi: 10.1038/nrc3419.
16. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science. 2005;308:1181-1184. doi: 10.1126/science.1109083.
17. Liu H, Fergusson MM, Wu JJ, Rovira II, Liu J, Gavrilova O, Lu T, Bao J, Han D, Sack MN, Finkel T. Wnt signaling regulates hepatic metabolism. Sci Signal. 2011;4:ra6. doi: 10.1126/scisignal.2001249.
18. Tenbaum SP, Ordopez-Morαn P, Puig I, Chicote I, Arquis O, Landolfi S, Fernαndez Y, Herance JR, Gispert JD, Mendizabal L, Aguilar S, Ramon y Cajal S, Schwartz S Jr, Vivancos A, Espvn E, Rojas S, Baselga J, Tabernero J, Mupoz A, Palmer HG. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med. 2012;18:892-901. doi: 10.1038/nm.2772.
19. Iyer S, Ambrogini E, Bartell SM, Han L, Roberson PK, de Cabo R, Jilka RL, Weinstein RS, OBrien CA, Manolagas SC, Almeida M. FOXOs attenuate bone formation by suppressing Wnt signaling. J Clin Invest. 2013;123:3409-3419. doi: 10.1172/JCI68049.
20. Naito AT, Sumida T, Nomura S, Liu ML, Higo T, Nakagawa A, Okada K, Sakai T, Hashimoto A, Hara Y, Shimizu I, Zhu W, Toko H, Katada A, Akazawa H, Oka T, Lee JK, Minamino T, Nagai T, Walsh K, Kikuchi A, Matsumoto M, Botto M, Shiojima I, Komuro I. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell. 2012;149:1298-1313. doi: 10.1016/j.cell.2012.03.047.
21. Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, Tadano N, Lu QW, Wang YY, Zhan DY, Mochizuki M, Kita S, Miwa Y, Takahashi-Yanaga F, Iwamoto T, Ohtsuki I, Sasaguri T. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res. 2007;101:185-194. doi: 10.1161/CIRCRESAHA.106.146670.
22. Hu Z, Klein JD, Mitch WE, Zhang L, Martinez I, Wang XH. MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Aging (Albany NY). 2014;6:160-175.
23. Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 2000;19:989-996. doi: 10.1093/emboj/19.5.989.
24. Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem. 2009;284:28319-28331. doi: 10.1074/jbc.M109.024406.
25. Okita K, Yonezawa K, Nishijima H, Hanada A, Ohtsubo M, Kohya T, Murakami T, Kitabatake A. Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation. 1998;98:1886-1891.
26. Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, Molkentin JD. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121:419-425. doi: 10.1161/CIRCULATIONAHA.109.882068.
27. Sanchez AM, Candau RB, Bernardi H. FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis. Cell Mol Life Sci. 2014;71:1657-1671. doi: 10.1007/s00018-013-1513-z.
28. Petry F, Botto M, Holtappels R, Walport MJ, Loos M. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J Immunol. 2001;167:4033-4037.
29. Gullestad L, Ueland T, Vinge LE, Finsen A, Yndestad A, Aukrust P. Inflammatory cytokines in heart failure: mediators and markers. Cardiology. 2012;122:23-35. doi: 10.1159/000338166.
30. Kuroda K, Kuang S, Taketo MM, Rudnicki MA. Canonical Wnt signaling induces BMP-4 to specify slow myofibrogenesis of fetal myoblasts. Skelet Muscle. 2013;3:5. doi: 10.1186/2044-5040-3-5.
31. Almeida M, Han L, Martin-Millan M, OBrien CA, Manolagas SC. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor-to forkhead box O-mediated transcription. J Biol Chem. 2007;282:27298-27305. doi: 10.1074/jbc. M702811200.
32. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K, Takeshita A. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res. 2000;86:152-157.
33. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, Nakamura Ki, Ichikawa K, Utsumi H, Takeshita A. Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation. 2001;104:134-136.